Derma Sciences (DSCI) Prelim. Q4, FY15 Sale Miss Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/11/2026
- Wall Street ends down as US-Iran peace optimism fades
- S&P 500 EPS growth above 20% is rare. Why 2027 may be at risk
- Goldman Sachs warns AI investment may be crowding out other business spending
- Why Wednesday's inflation print could provide the next dovish catalyst
- Tesla needs Robotaxi flywheel proof to boost investor conviction: Morgan Stanley
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
Oppenheimer Cuts Price Target Following Derma Sciences' (DSCI) 4Q Preliminary Results
January 8, 2016 9:23 AM ESTOppenheimer maintained an Outperform rating on Derma Sciences (NASDAQ: DSCI), and cut the price target to $7.00 (from $8.00), following the company's preliminary 4Q15 results. 4Q sales were ~$1.9M below on Advanced Wound Care (AWC) and ~$1.5M below on Traditional Wound Care (TWC).
Analyst Steven Lichtman... More
Canaccord Genuity Downgrades Derma Sciences (DSCI) to Hold
January 7, 2016 9:43 AM ESTCanaccord Genuity downgraded Derma Sciences (NASDAQ: DSCI) from Buy to Hold.
For an analyst ratings summary and ratings history on Derma Sciences click here. For more ratings news on Derma Sciences click here.
Shares of Derma Sciences closed at $4.32 yesterday.
... More